Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial"

Publication date

2017

Authors

Westerink, J.ISNI 0000000388385904
Visseren, Frank L.J.ISNI 0000000389493675

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

taverne

Abstract

Keywords

Letter, Taverne, Cardiology and Cardiovascular Medicine, Letter

Citation

Westerink, J & Visseren, F 2017, 'Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting : The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial"', Arteriosclerosis, Thrombosis and Vascular Biology, vol. 37, no. 5, e53. https://doi.org/10.1161/ATVBAHA.117.309295